Collection of tissue samples for vasculitis research

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to gather existing tissue specimens from patients enrolled in various Vasculitis Clinical Research Consortium (VCRC) studies. The collected specimens, which include biopsies from organs such as the kidney, lung, and skin, will be analyzed alongside clinical data to enhance understanding of vasculitis and related autoimmune diseases. The goal is to identify potential causes and develop new diagnostic tests and therapies for these conditions. Importantly, biopsies are not performed specifically for this study; rather, consent is sought to use samples collected during routine care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* A participant will be deemed eligible for this study if the participant is/was enrolled in another one of the VCRC observational/longitudinal protocols (5502, 5503, 5504, 5505, 5506, 5507, 5563) and/or one of the VCRC interventional studies (5522, 5523, 5526, 5527, or 5562).

Exclusion Criteria:

* Inability to give informed consent (or their guardians in the case of children) and to sign the consent form.
* Unwilling to allow the use of their tissue for research.

Where it's running

• University of Pennsylvania
  Philadelphia, Pennsylvania, United States Recruiting
• St. Joseph's Healthcare
  Hamilton, Ontario, Canada Recruiting
• University of Toronto Mount Sinai Hospital
  Toronto, Ontario, Canada Recruiting
• Brigham and Women's Hospital
  Boston, Massachusetts, United States Completed
• Boston University School of Medicine
  Boston, Massachusetts, United States Completed
• Cleveland Clinic
  Cleveland, Ohio, United States Completed

Study contacts

• Study coordinator: Katie Doyle
• Email: Kathryn.Logue@pennmedicine.upenn.edu

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-time DNA analysis for vasculitis

  This study is testing whether analyzing DNA from people with different types of vasculitis can help find genetic factors that increase the risk of these diseases and lead to better treatments.

  Recruiting at 4 sites University of Pennsylvania · Los Angeles, California and 13 other locations · NCT01241305

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

• Nationwide registry for systemic autoimmune and autoinflammatory diseases in Armenia

  This study is trying to gather information about systemic autoimmune and autoinflammatory diseases in Armenia to better understand how these conditions progress and how they are treated.

  Recruiting at 4 sites Santé Arménie French-Armenian Research Center · Yerevan and 5 other locations · NCT05904301

• Understanding the natural history and outcomes of systemic vasculitis

  This study is trying to understand how systemic vasculitis affects people over time and what signs can help predict how the disease will progress, involving both patients with vasculitis and healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT02257866

• Long-term observation of Eosinophilic Granulomatosis With Polyangiitis

  This study is trying to find new ways to track how Eosinophilic Granulomatosis With Polyangiitis affects people over time by looking at their health and collecting samples.

  Recruiting at 6 sites University of Pennsylvania · San Diego, California and 14 other locations · NCT00315380

• I-FABP as a Predictor of Gut Involvement in Pediatric IgA Vasculitis

  This study checks if a blood marker called I-FABP can flag gut involvement in kids with IgA vasculitis by testing blood at diagnosis and again in 2–4 weeks.

  Recruiting Bursa City Hospital · Bursa, Bursa · NCT07664228

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.